H3F3B p.K27I変異型拡散ミドルライン・グリオマは,H3K27変異型拡散ミドルライン・グリオマの独特のサブタイプである
Lei Cheng1, Min Zhou2,3, Tao Luo4
1Department of Neurosurgery, Xuanwu Hospital, International Neuroscience Institute, Capital Medical University, #45 Changchun Street, Western District, Beijing, 100053, China.
Acta neuropathologica communications
|August 24, 2025
まとめ
H3F3B変異は,拡散性ミドルライン・グリオマ (DMG) で,H3K27トリメチル化が失われ,予後が悪い. これらの腫瘍は独特のメチル化パターンと頻繁なPPM1D/ NF1変異を持つ独特の分子サブタイプを形成する.
科学分野:
- 神経腫瘍学
- ガンゲノミクス
- エピジェネティクス
背景:
- ディフュース・ミッドライン・グリオマ (DMG) は,異なる分子サブタイプを持つ致命的な脳腫瘍である.
- H3K27変異型DMGには,H3.3変異型,H3.1/H3.2変異型,EZHIP過剰発現型,EGFR変異型が含まれている.
- H3F3B変異がDMGの病原性および臨床結果に与える役割は不明である.
研究 の 目的:
- H3F3B変異性の拡散性ミドルライン・グリオマの 臨床的および分子的特徴を調査する.
- H3F3B変異がH3K27トリメチル化と患者の予後に影響を及ぼすことを決定する.
- H3F3B変異型DMGの独特の分子特性と潜在的なグリオマゲネシスメカニズムの描写.
主な方法:
- 9人のH3F3B変異のDMG患者からの臨床および放射線学的データの遡及的収集.
- DNAメチル化プロファイリングと 次世代の腫瘍サンプルシーケンシング
- H3K27me3発現の免疫ヒストロケミストリーとメチル化データの無監督のt-分布ストキャスティック隣人埋め込み (t-SNE) 分析.
主要な成果:
- すべての腫瘍は体内のH3F3B p.K27I変異とH3K27me3発現の喪失を示した.
- H3F3B変異のDMGは,他のH3K27me3損失グリオマとは異なるメチル化クラスタを形成した.
- PPM1DとNF1の頻度の高い変異が観察され,予後はH3K27M変異のDMGと同等であった.
結論:
- H3F3B変異は,H3K27トリメチル化損失と悪い結果につながる,DMGの明確な分子ドライバーです.
- H3F3B変異のDMGは,特徴的なDNAメチル化と変異プロファイルを持つユニークなサブタイプを表しています.
- これらの発見は,H3F3B変異体と正規のH3K27M変異体DMGの間の異なった結晶生成経路を示唆する.
関連する概念動画
02:32Position-effect Variegation
5.6K
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
5.6K
02:30Histone Variants at the Centromere
4.0K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.0K
02:53Conservative Site-specific Recombination and Phase Variation
5.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.7K
02:39lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K